Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Brown

Showing results (221-230 of 259) with videos related to

Pageof 26
Sort By:
Ophthalmology|June 26, 2012
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edemaPeter A Campochiaro, David M Brown, Andrew Pearson, et al.
Science (New York, N.Y.)|March 21, 2024
Efficient formation of single-copy human artificial chromosomesCraig W Gambogi, Gabriel J Birchak, Elie Mer, et al.
JAMA Ophthalmology|August 3, 2023
Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical TrialCharles C Wykoff, David M Brown, Kimberly Reed, et al.
Journal of Personalized Medicine|June 28, 2023
Demographic and Socioeconomic Factors in Prospective Retina-Focused Clinical Trial Screening and EnrollmentJessica A Cao, Sagar B Patel, Calvin W Wong, et al.
JAMA Ophthalmology|August 5, 2021
Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical TrialDavid M Brown, Charles C Wykoff, David Boyer, et al.
Progress in Retinal and Eye Research|May 24, 2021
Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disordersRichard F Spaide, Chui Ming Gemmy Cheung, Hidetaka Matsumoto, et al.
Retina (Philadelphia, Pa.)|June 20, 2024
MANAGEMENT OF LARGE FULL-THICKNESS MACULAR HOLES: Long-Term Outcomes of Internal Limiting Membrane Flaps and Internal Limiting Membrane PeelsKaitlyn Richards, Ankit Kadakia, Charles C Wykoff, et al.
Nutrients|March 13, 2025
Short-Term Magnesium Supplementation Has Modest Detrimental Effects on Cycle Ergometer Exercise Performance and Skeletal Muscle Mitochondria and Negligible Effects on the Gut Microbiota: A Randomized Crossover Clinical TrialMatthew C Bomar, Taylor R Ewell, Reagan L Brown, et al.
Vision (Basel, Switzerland)|November 24, 2025
Geographic Atrophy Progression in Clinical Practice Before and After Pegcetacoplan TreatmentJessica A Cao, Avery W Zhou, Gail M Teagle, et al.
American Journal of Ophthalmology|January 17, 2022
KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular EdemaDavid M Brown, Andrés Emanuelli, Francesco Bandello, et al.
Pageof 26

Showing results (221-230 of 259) with videos related to

Sort By:
Pageof 26
Ophthalmology|June 26, 2012
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edemaPeter A Campochiaro, David M Brown, Andrew Pearson, et al.
Science (New York, N.Y.)|March 21, 2024
Efficient formation of single-copy human artificial chromosomesCraig W Gambogi, Gabriel J Birchak, Elie Mer, et al.
JAMA Ophthalmology|August 3, 2023
Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical TrialCharles C Wykoff, David M Brown, Kimberly Reed, et al.
Journal of Personalized Medicine|June 28, 2023
Demographic and Socioeconomic Factors in Prospective Retina-Focused Clinical Trial Screening and EnrollmentJessica A Cao, Sagar B Patel, Calvin W Wong, et al.
JAMA Ophthalmology|August 5, 2021
Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical TrialDavid M Brown, Charles C Wykoff, David Boyer, et al.
Progress in Retinal and Eye Research|May 24, 2021
Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disordersRichard F Spaide, Chui Ming Gemmy Cheung, Hidetaka Matsumoto, et al.
Retina (Philadelphia, Pa.)|June 20, 2024
MANAGEMENT OF LARGE FULL-THICKNESS MACULAR HOLES: Long-Term Outcomes of Internal Limiting Membrane Flaps and Internal Limiting Membrane PeelsKaitlyn Richards, Ankit Kadakia, Charles C Wykoff, et al.
Nutrients|March 13, 2025
Short-Term Magnesium Supplementation Has Modest Detrimental Effects on Cycle Ergometer Exercise Performance and Skeletal Muscle Mitochondria and Negligible Effects on the Gut Microbiota: A Randomized Crossover Clinical TrialMatthew C Bomar, Taylor R Ewell, Reagan L Brown, et al.
Vision (Basel, Switzerland)|November 24, 2025
Geographic Atrophy Progression in Clinical Practice Before and After Pegcetacoplan TreatmentJessica A Cao, Avery W Zhou, Gail M Teagle, et al.
American Journal of Ophthalmology|January 17, 2022
KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular EdemaDavid M Brown, Andrés Emanuelli, Francesco Bandello, et al.
Pageof 26